JPMorgan lowered the firm’s price target on Nutanix (NTNX) to $81 from $90 and keeps an Overweight rating on the shares. The company reported a “robust” fiscal Q4 but the bigger focus will be on the fiscal 2026 guidance which calls for 15% revenue growth following 18% growth in 2025, the analyst tells investors in a research note. The firm believes the outlook is drive concerns over Nutanix cycling past the early innings of the tailwinds in relation to the VMware opportunity. JPMorgan expects the shares will “remain muted” in the near-term.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTNX:
- Positive Outlook and Buy Rating for Nutanix Driven by Strong Financial Performance and Strategic Partnerships
- Nutanix’s Strong Performance and Promising Prospects: Buy Rating Affirmed by Jason Ader
- Nutanix price target lowered to $82 from $94 at Barclays
- Nutanix Inc. Reports Strong Fiscal 2025 Results
- Nutanix Announces Strong Fiscal Year 2025 Results